38 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Oxbridge Re Holdings Limited OXBR rose 103.4% to $2.38 in pre-market trading after the company swung to a profit in the second quarter.
• Pfenex Inc. PFNX shares rose 62.8% to $12.50 in pre-market trading. Ligand Pharmaceuticals Inc. LGND announced plans to acquire Pfenex for $12 per share in cash.
• Equillium, Inc. EQ rose 25.9% to $12.65 in pre-market trading after the company reported positive interim data from the first two cohorts of the Phase 1b open label, dose escalation portion of the EQUATE study of itolizumab.
• The Peck Company Holdings, Inc. PECK rose 23.8% to $5.67 in pre-market trading after the company posted a lower Q2 loss and announced plans to buy Sunworks in a stock deal.
• Clearside Biomedical, Inc. CLSD rose 22.9% to $2.20 in pre-market trading after the company reported a narrower Q2 loss and announced the U.S. FDA acceptance of investigational new drug application for CLS-AX administered in suprachoroidal space.
• Koss Corporation KOSS rose 23% to $2.95 in pre-market trading. On Monday, it was reported that Apple was suing Koss for breaching the parties' confidentiality agreement.
• Fortress Biotech, Inc. FBIO rose 20.5% to $4.00 in pre-market trading after the company reported a rise in Q2 EPS and sales results,
• RCI Hospitality Holdings Inc RICK rose 14.3% to $16.62 in pre-market trading after the company reported better-than-expected Q3 results.
• Immutep Limited IMMP rose 14% to $1.53 in pre-market trading after the company announced it has been granted a US Patent for Eftilagimod Alpha in Chemo-immunotherapy combination.
• Nautilus, Inc. NLS rose 11.7% to $13.80 in pre-market trading after reporting a rise in Q2 sales.
• Nio Inc – ADR NIO rose 9.9% to $15.61 in pre-market trading after the company reported better-than-expected Q2 results. The company also issued Q3 sales guidance above analyst estimates and announced it expects Q3 vehicle deliveries to increase 129.2%-139.6% year-over-year.
• Carparts.Com Inc PRTS rose 9.4% to $15.00 in pre-market trading after the company swung to a profit in the second quarter.
• Sunesis Pharmaceuticals, Inc. SNSS rose 8.5% to $0.3535 in pre-market trading ahead of quarterly earnings.
• LightInTheBox Holding Co., Ltd. LITB rose 8.1% to $3.50 in pre-market trading after jumping more than 18% on Monday.
• Sorrento Therapeutics, Inc. SRNE rose 7.4% to $20.19 in pre-market trading after surging over 30% on Monday.
• Qurate Retail Inc QRTEA shares rose 7.4% to $12.40 in pre-market trading after the company reported better-than-expected Q2 results.
• Francesca's Holdings Corporation FRAN shares rose 7% to $5.93 in pre-market trading after gaining 9% on Monday.
• DHT Holdings Inc DHT rose 6.3% to $5.96 in pre-market trading after the company reported better-than-expected Q2 sales.
• Borr Drilling Limited BORR rose 5% to $1.06 in pre-market trading. Usio is expected to report Q2 results on August 14.
• Adverum Biotechnologies Inc ADVM rose 4.3% to $19.50 in pre-market trading after the company announced "positive" interim data from Cohorts 1-4 of the OPTIC Phase 1 clinical trial of ADVM-022 intravitreal inject gene therapy.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Mesoblast Limited MESO fell 27.1% to $12.70 in pre-market trading as traders circulated Aug. 13-dated FDA briefing doc for the company’s Biologics License Application for Remestemecl-L.
• Ideanomics Inc IDEX fell 16.9% to $1.48 in pre-market trading after the company reported a drop in Q2 EPS and sales.
• Catalyst Pharmaceuticals Inc CPRX fell 16.1% to $3.58 in pre-market trading after the company reported Q2 earnings results.
• Sunworks, Inc. SUNW fell 15.3% to $1.05 in pre-market trading after the company reported a Q2 loss. The Peck Co. also announced plans to buy Sunworks in a stock deal.
• NGL Energy Partners LP NGL fell 11.3% to $4.40 in pre-market trading after the company reported worse-than-expected Q1 earnings.
• Adial Pharmaceuticals, Inc. ADIL fell 10.3% to $1.65 in pre-market trading.
• ZoomInfo Technologies Inc ZI fell 9.7% to $39.00 in pre-market trading despite reporting better-than-expected Q2 results.
• Naked Brand Group Limited NAKD fell 9% to $0.3825 in pre-market trading after the company filed for shelf of up to 57.4 million ordinary shares by selling stockholders.
• CymaBay Therapeutics Inc CBAY fell 8.7% to $6.30 in pre-market trading after the company issued Q2 earnings results. It also noted it stopped its review of strategic options and plans to focus on reinstating the clinical development program for seladelpar in PBC.
• Tilray Inc TLRY fell 8.4% to $7.30 in pre-market trading after the company reported downbeat Q2 results.
• Inovio Pharmaceuticals, Inc. INO fell 8.3% to $17.42 in pre-market trading after the company reported downbeat results for its second quarter on Monday. The company also expects its COVID-19 vaccine to enter mid-to-late stage human trials in September.
• Trevena, Inc. TRVN fell 8% to $2.88 in pre-market trading. Trevena shares jumped around 32% on Monday after the company announced the FDA has approved its OLINVYK injection.
• Omeros Corporation OMER fell 7.4% to $19.75 in pre-market trading after the company reported a wider Q2 loss and announced a $125 million common stock offering. Omeros shares jumped over 50% on Monday after the company reported recovery and survival of all patients in a study evaluating Narsoplimab for the treatment of Covid-19-associated Acute Respiratory Distress Syndrome.
• iFresh Inc. IFMK fell 6.9% to $0.95 in pre-market trading. On Monday, iFresh agreed to acquire Jiuxiang Blue Sky Technology.
• Hertz Global Holdings Inc HTZ shares fell 4.7% to $1.61 in pre-market trading after the company reported Q2 EPS and sales results were down year over year.
• ANGI Homeservices Inc ANGI fell 4% to $14.88 in pre-market trading in sympathy with its parent company, IAC, after it released weak Q2 earnings results.
• IAC/Interactivecorp IAC fell 3.8% to $126.25 in pre-market trading after the company reported a loss during the second quarter.
• Occidental Petroleum Corporation OXY fell 3.6% to $15.89 in pre-market trading as the company reported weaker-than-expected earnings for its second quarter after recording $6.6 billion in impairment charges.